WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways

被引:52
作者
Chen, Tianli [1 ]
Li, Kangshuai [1 ]
Liu, Zengli [1 ]
Liu, Jialiang [1 ]
Wang, Yue [1 ]
Sun, Rongqi [1 ]
Li, Zhipeng [1 ,2 ]
Qiu, Bo [1 ]
Zhang, Xiaoming [3 ]
Ren, Guangli [4 ]
Xu, Yunfei [1 ]
Zhang, Zongli [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Gen Surg, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China
[2] Shandong Second Prov Gen Hosp, Shandong Prov ENT Hosp, Dept Gen Surg, Jinan, Peoples R China
[3] Linyi Peoples Hosp, Dept Gen Surg, Linyi, Shandong, Peoples R China
[4] Shandong Univ, Shandong Prov Hosp 3, Dept Gen Surg, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
C-MYC; HYPOXIA; CHOLANGIOCARCINOMA; CHROMATIN; HIF; PROGRESSION; VALIDATION; INHIBITION; EXPRESSION; COMPLEX;
D O I
10.1016/j.ymthe.2021.02.017
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cholangiocarcinoma (CCA) is a highly aggressive malignancy with extremely poor prognoses. The oncogenic role and prognostic value of c-Myc in CCA is not well elucidated. WD repeat domain 5 (WDR5) is a critical regulatory factor directly interacting with c-Myc to regulate c-Myc recruitment at chromosomal locations, but the interaction of WDR5 and c-Myc in CCA was uncovered. In our study, we detected WDR5 and c-Myc expression in all CCA types, including intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) CCA, and evaluated their prognostic significance. Consequently, we demonstrated that WDR5 was significantly correlated with poor prognosis of CCA and that WDR5 and c-Myc co-expression was a more sensitive prognostic factor. With in vitro and in vivo experiments and bioinformatics, we showed that WDR5 interacted with the Myc box IIIb(MBIIIb) motif of c-Myc and facilitated Myc-induced HIF1A transcription, thereby promoting the epithelial-mesenchymal transition (EMT), invasion, and metastasis of CCA. Moreover, WDR5 enhanced hypoxia-inducible factor 1 subunit alpha (HIF-1 alpha) accumulation by binding with histone deacetylase 2 (HDAC2) and increasing histone 3 lysine 4 acetylation (H3K4ac) deacetylation of the prolyl hydroxylase domain protein2 (PHD2) promoter, resulting in the attenuation of chromatin opening and PHD2 expression, and eventually leading to HIF-1 alpha stabilization and accumulation. In conclusion, WDR5 facilitated EMT and metastasis of CCA by increasing HIF-1 alpha accumulation in a Myc-dependent pathway to promote HIF-1 alpha transcription and a Myc-independent pathway to stabilize HIF-1 alpha.
引用
收藏
页码:2134 / 2150
页数:17
相关论文
共 59 条
  • [11] MYC, Metabolism, Cell Growth, and Tumorigenesis
    Dang, Chi V.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2013, 3 (08):
  • [12] A NULL C-MYC MUTATION CAUSES LETHALITY BEFORE 10.5 DAYS OF GESTATION IN HOMOZYGOTES AND REDUCED FERTILITY IN HETEROZYGOUS FEMALE MICE
    DAVIS, AC
    WIMS, M
    SPOTTS, GD
    HANN, SR
    BRADLEY, A
    [J]. GENES & DEVELOPMENT, 1993, 7 (04) : 671 - 682
  • [13] BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
    Delmore, Jake E.
    Issa, Ghayas C.
    Lemieux, Madeleine E.
    Rahl, Peter B.
    Shi, Junwei
    Jacobs, Hannah M.
    Kastritis, Efstathios
    Gilpatrick, Timothy
    Paranal, Ronald M.
    Qi, Jun
    Chesi, Marta
    Schinzel, Anna C.
    McKeown, Michael R.
    Heffernan, Timothy P.
    Vakoc, Christopher R.
    Bergsagel, P. Leif
    Ghobrial, Irene M.
    Richardson, Paul G.
    Young, Richard A.
    Hahn, William C.
    Anderson, Kenneth C.
    Kung, Andrew L.
    Bradner, James E.
    Mitsiades, Constantine S.
    [J]. CELL, 2011, 146 (06) : 903 - 916
  • [14] Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
    DeOliveira, Michelle L.
    Cunningham, Steven C.
    Cameron, John L.
    Kamangar, Farin
    Winter, Jordan M.
    Lillemoe, Keith D.
    Choti, Michael C.
    Yeo, Charles J.
    Schulick, Richard D.
    [J]. ANNALS OF SURGERY, 2007, 245 (05) : 755 - 762
  • [15] TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB-EGF Expression and Proteolytic Cleavage
    Dong, Zhao-Ru
    Sun, Dong
    Yang, Ya-Fei
    Zhou, Wei
    Wu, Rui
    Wang, Xiao-Wei
    Shi, Kai
    Yan, Yu-Chuan
    Yan, Lun-Jie
    Yao, Cheng-Yu
    Chen, Zhi-Qiang
    Zhi, Xu-Ting
    Li, Tao
    [J]. HEPATOLOGY, 2020, 72 (03) : 923 - 939
  • [16] C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
    Epstein, ACR
    Gleadle, JM
    McNeill, LA
    Hewitson, KS
    O'Rourke, J
    Mole, DR
    Mukherji, M
    Metzen, E
    Wilson, MI
    Dhanda, A
    Tian, YM
    Masson, N
    Hamilton, DL
    Jaakkola, P
    Barstead, R
    Hodgkin, J
    Maxwell, PH
    Pugh, CW
    Schofield, CJ
    Ratcliffe, PJ
    [J]. CELL, 2001, 107 (01) : 43 - 54
  • [17] HIF Inhibitors: Status of Current Clinical Development
    Fallah, Jaleh
    Rini, Brian I.
    [J]. CURRENT ONCOLOGY REPORTS, 2019, 21 (01)
  • [18] PAF1 complex component Leo1 helps recruit &ITDrosophila &ITMycto promoters
    Gerlach, Jennifer M.
    Furrer, Michael
    Gallant, Maria
    Birkel, Dirk
    Baluapuri, Apoorva
    Wolf, Elmar
    Gallant, Peter
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (44) : E9224 - E9232
  • [19] Histone modification and replacement in chromatin activation
    Goll, MG
    Bestor, TH
    [J]. GENES & DEVELOPMENT, 2002, 16 (14) : 1739 - 1742
  • [20] Moonlighting with WDR5: A Cellular Multitasker
    Guarnaccia, Alissa duPuy
    Tansey, William Patrick
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (02):